| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/22/2001 | CA2386559A1 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | CA2384991A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2383003A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 03/22/2001 | CA2382067A1 Recombinant microorganisms |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2381006A1 Antisense modulation of transforming growth factor-.beta. expression |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/21/2001 | EP1085092A1 Phosphodiesterase enzymes |
| 03/21/2001 | EP1085089A2 Human cyclic nucleotide phosphodiesterase |
| 03/21/2001 | EP1084709A1 Oral recombinant lactobacilli vaccines |
| 03/21/2001 | EP1084278A1 Detection of dna, rna and proteins |
| 03/21/2001 | EP1084274A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1084255A1 Tankyrase, a trf1 binding protein |
| 03/21/2001 | EP1084252A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 03/21/2001 | EP1084251A2 Attenuated pestiviruses |
| 03/21/2001 | EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 03/21/2001 | EP1084245A1 Human receptor tyrosine kinase |
| 03/21/2001 | EP1084236A1 Novel adenoviral vectors for gene therapy |
| 03/21/2001 | EP1084232A1 Genetically-modified fibroblasts and the use thereof |
| 03/21/2001 | EP1084230A2 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 03/21/2001 | EP1084135A1 The human kidney specific gene kk86 |
| 03/21/2001 | EP1083968A1 FLOW-THROUGH ELECTROPORATION SYSTEM FOR $i(EX VIVO) GENE THERAPY |
| 03/21/2001 | EP1083951A1 Methods of delivering aerosolized polynucleotides to the respiratory tract |
| 03/21/2001 | EP1083945A1 Encapsulation devices with strand, yarn or mesh core |
| 03/21/2001 | EP1083935A1 Prosthetic implant and methods of use for therapeutic gene expression |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |
| 03/21/2001 | EP1083923A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1083916A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
| 03/21/2001 | EP1083910A1 nrdE |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083886A1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 03/21/2001 | EP1083882A1 A hepatocyte targeting polyethylene glyco-grafted poly-l-lysine polymeric gene carrier |
| 03/21/2001 | EP0797678B1 Hybrid adenovirus-aav virus and method of use thereof |
| 03/21/2001 | CN1288388A Stabilization of lipid DNA formulations during nebulization |
| 03/21/2001 | CN1288057A Coded novel human angiotensin II-1 receptor related protein gene, and application and prepn. method therefor |
| 03/20/2001 | US6204371 Compositions and methods for the treatment and diagnosis of immune disorders |
| 03/20/2001 | US6204251 Ocular gene therapy |
| 03/20/2001 | US6204250 Immunization of infants |
| 03/20/2001 | US6204063 Nucleotide sequences coding mitochondrial polypeptide; for controlling metabolism in plants |
| 03/20/2001 | US6204061 Culturing cells with adjusted nucleotide sequences; transform cells with vector, detect cell with genome adjustment, propagate cells |
| 03/20/2001 | US6204060 Viral vectors and line for gene therapy |
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204055 Antisense inhibition of Fas mediated signaling |
| 03/20/2001 | US6204052 Nucleotide sequence associated with preferential gene expression; for use in cancer gene therapy and treatment of autoimmune diseases or infections |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204035 Enzymatic protein associated with modulation of coagulation; for preparing tissues, and organs for grafting; anticoauglant; for diagnosis of defective coagulation in humans; for treating autoimmune and inflammatory diseases |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6204000 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 03/20/2001 | US6203991 Inhibition of smooth muscle cell migration by heme oxygenase I |
| 03/20/2001 | US6203976 Drug screening using eukaryotic cells with dna construct of regulatory sequence and promoter linked to reporter gene, contacting with chemical, quantitatively determining signal produced, comparing to controls, then mixing with carrier |
| 03/20/2001 | US6203975 Adenovirus and method of use thereof |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203795 Polypeptide; antibody h23 recognizes tumor antigen expressed on breast cancer cells |
| 03/15/2001 | WO2001018546A2 Screening for inhibitors of 'paired helical filaments' |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018224A1 Adenoviral vectors modified for increased and persistent expression of the cystic fibrosis transmembrane conductance regulator gene in human airway epithelia |
| 03/15/2001 | WO2001018223A1 Paramyxoviruses having modified transcription initiation sequence |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018208A2 Interferon induced polynucleotides and proteins encoded thereby |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018193A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018056A2 Method of gene therapy for improving the efficiency of cancer therapy |
| 03/15/2001 | WO2001018048A2 Smooth muscle cell promoter and uses thereof |
| 03/15/2001 | WO2001018043A2 Neurogenic compositions and methods |
| 03/15/2001 | WO2001018039A2 INCREASED PRODUCTION OF INTERFERON-$g(a) |
| 03/15/2001 | WO2001018038A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018024A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | WO2001018023A1 Antisense modulation of pi3 kinase p110 beta expression |
| 03/15/2001 | WO2001018022A1 52 human secreted proteins |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018015A1 Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001017547A2 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 03/15/2001 | WO2001017537A2 Methods and compositions for reducing immune response |
| 03/15/2001 | WO2001017532A1 Human neuropeptide receptor |
| 03/15/2001 | WO2000077198A3 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/15/2001 | WO2000071152A9 Fibroblast growth factor 10 |
| 03/15/2001 | WO2000066178A9 Lim mineralization protein splice variants |
| 03/15/2001 | WO2000064468A3 Therapeutic compositions and methods for enhancing angiogenesis |
| 03/15/2001 | WO2000061610A3 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 03/15/2001 | WO2000053730A3 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 03/15/2001 | WO2000049167A8 Latency-associated regulatory region from herpesvirus saimiri (hvs) |
| 03/15/2001 | WO2000047733A9 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 03/15/2001 | WO1999062545A3 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS |
| 03/15/2001 | WO1999061067A8 Gene expression method |